Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article by Men’s Health magazine cited a study published in the August 2015 issue of The American Journal of Managed Care®. The study, “Opportunity Costs of Ambulatory Medical Care in the United States,” showed substantial time costs attributed to individuals and society for ambulatory medical care in the United States.
Taletrectinib Recommended in NCCN Guidelines for ROS1-Positive NSCLC
July 31st 2025Taletrectinib was added to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology as a preferred option for the first-line and subsequent treatment of advanced ROS1-positive non–small cell lung cancer (NSCLC).
Read More